Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Atomo Diagnostics Ltd. ( (AU:AT1) ) has provided an announcement.
Atomo Diagnostics Ltd. has announced the quotation of 31,729,730 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of July 3, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility and market presence, potentially impacting its operations and stakeholder interests positively.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. operates in the medical diagnostics industry, focusing on the development and commercialization of rapid diagnostic test devices. The company is known for its innovative products that provide quick and accurate results, catering primarily to the healthcare sector.
Average Trading Volume: 691,516
Technical Sentiment Signal: Sell
Current Market Cap: A$10.32M
For detailed information about AT1 stock, go to TipRanks’ Stock Analysis page.